了解容正-历史

About Rozenmed

This is a ten-year period of sharpening a sword
China’s firststerility assurance systemconstruction promotion

Introduction

History

Purpose

Story

Responsibility

History

励精图治，开拓进取 After nearly ten years of stormy journey and more than ten years of hard work, has engraved innovation into its genes, deeply researched industry trends and keenly explored cutting-edge pain points, allowing Rozenmed to come to the stage of group development today, with business covering the whole health industry chain such as medical and pharmaceuticals.

1970

Former life of Pujin Pharmaceuticals Established in 1970 (Xuyi Pharmaceutical Factory, Jiangsu Province)

2012 2021 In 2012, the first one passed the review and certification of the new GMP version of Chinese medicine injection 2014 In 2014, Jiangsu Anger Pharmaceutical Company Limited changed its name to Jiangsu Pujin Pharmaceutical Company Limited, with products in the direction of anti-tumor and anti-infection. Since the products were launched, they have realized the essence of drugs to cure diseases and make outstanding contributions to the clinic. 1970 2014 2012 2021 In 2021, we researched and succeeded in the true sense of ultra-clean technology, which has three main features, dry, low temperature, fast and thorough, and achieved the standard of treatment of endotoxins, bacteria and particles on the surface of materials In the same year, Rozenmed announced that we had achieved a milestone in the cleanliness standard, which is highly valued in the pharmaceutical field.

1999 In 1999, the state-owned assets were restructured and renamed as Jiangsu Ange Pharmaceutical Company. 2013

Rozenmed Established Founded in 2013, based on the establishment of a pharmaceutical marketing team, we have formed a large network of clinical terminal experts and distribution channels in China. In the process, we have discovered a disruptive trauma treatment technology, completely physical non-sensory treatment, which solves the pain and fear of acute and chronic trauma patients for trauma disinfection, the technology has matured and is in the process of applying for national Class III device approval, so stay tuned!

2017

Cold Plasma Medical Research InstituteIn The process of mutual cooperation and communication between Rorenmed and DuPont in 2017, it was found that DuPont's raw material-Tyvek initial source of contamination was a major pain point in the industry, and the company studied the cleaning technology for up to five years and finally discovered the mature research of cold isotope in the field of industrial cleaning.

1999 2017 2013